Endothelial Progenitor Cells: Their Potential in the Placental Vasculature and Related Complications

Placenta

Volumn 31, Issue 1, 2010, Pages 1-10

  Sipos, P I ^a   Crocker, I P ^a   Hubel, C A ^b   Baker, P N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Embryogenesis; Endothelial progenitor cells; IUGR; Placenta; Pre eclampsia

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN II ANTAGONIST; ANTINEOPLASTIC AGENT; CANDESARTAN; ERYTHROPOIETIN; ESTRADIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILBESARTAN; LOSARTAN; MATRIX METALLOPROTEINASE; NIFEDIPINE; OLMESARTAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PROSTAGLANDIN E1; SCLEROPROTEIN; SILDENAFIL; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL HOMING; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIUM CELL; FETUS DEVELOPMENT; FLOW CYTOMETRY; HUMAN; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; OBSTETRICS; PATHOPHYSIOLOGY; PHENOTYPE; PLACENTA; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; STEM CELL; VASCULARIZATION;

ANIMALS; CELL CULTURE TECHNIQUES; EMBRYONIC DEVELOPMENT; ENDOTHELIAL CELLS; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PLACENTAL CIRCULATION; PREGNANCY; PREGNANCY COMPLICATIONS; STEM CELLS;

EID: 71649105106     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.10.006     Document Type: Article

References (111)

1. Asahara T., Murohara T., Sullivan A., Silver M., Van Der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 5302 (1997) 964-967
2. Fadini G.P., Schiavon M., Avogaro A., and Agostini C. The emerging role of endothelial progenitor cells in pulmonary hypertension and diffuse lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 2 (2007) 85-93
3. Jung K.H., Chu K., Lee S.T., Park H.K., Kim D.H., Kim J.H., et al. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease. J Cereb Blood Flow Metab 11 (2008) 1795-1803
4. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 7 (2003) 593-600
5. Loomans C.J., De Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., De Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 1 (2004) 195-199
6. Chen J.Z., Zhang F.R., Tao Q.M., Wang X.X., and Zhu J.H. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 3 (2004) 273-280
7. Imanishi T., Moriwaki C., Hano T., and Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 10 (2005) 1831-1837
8. Herbrig K., Pistrosch F., Foerster S., and Gross P. Endothelial progenitor cells in chronic renal insufficiency. Kidney Blood Press Res 1 (2006) 24-31
9. Kondo T., Hayashi M., Takeshita K., Numaguchi Y., Kobayashi K., Iino S., et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 8 (2004) 1442-1447
10. Boilson B.A., Kiernan T.J., Harbuzariu A., Nelson R.E., Lerman A., and Simari R.D. Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med 8 (2008) 489-496
11. Ruifrok W.P., de B.R.A., Iwakura A., Silver M., Kusano K., Ra T., et al. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Vasc Med 1 (2009) 29-36
12. Hu Z., Zhang F., Yang Z., Yang N., Zhang D., Zhang J., et al. Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia. J Biomed Sci 4 (2008) 509-517
13. Madeddu P., Kraenkel N., Barcelos L.S., Siragusa M., Campagnolo P., Oikawa A., et al. Phosphoinositide 3-kinase gamma gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions. Arterioscler Thromb Vasc Biol 1 (2008) 68-76
14. Oh I.Y., Yoon C.H., Hur J., Kim J.H., Kim T.Y., Lee C.s., et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 12 (2007) 3891-3899
15. Choi K., Kennedy M., Kazarov A., Papadimitriou J.c., and Keller G.A. Common precursor for hematopoietic and endothelial cells. Development 4 (1998) 725-732
16. Nishikawa S.I., Nishikawa S., Hirashima M., Matsuyoshi N., and Kodama H. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages. Development 9 (1998) 1747-1757
17. Rafii S., and Lyden D. Cancer: a few to flip the angiogenic switch. Science 5860 (2008) 163-164
18. Anghelina M., Krishnan P., Moldovan L., and Moldovan N.I. Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 2 (2006) 529-541
19. Jin D.K., Shido K., Kopp H.G., Petit I., Shmelkov S.V., Young L.M., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 5 (2006) 557-567
20. Zentilin L., Tafuro S., Zacchigna S., Arsic N., Pattarini L., Sinigaglia M., et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 9 (2006) 3546-3554
21. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 1 (2000) 71-77
22. Sieveking D.P., Buckle A., Celermajer D.S., and Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 6 (2008) 660-668
23. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 9 (2004) 2752-2760
24. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 1 (2001) E1-E7
25. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., and Shaper J.H. Antigenic analysis of hematopoiesis. iii. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1 (1984) 157-165
26. Andrews R.G., Singer J.W., and Bernstein I.D. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 3 (1986) 842-845
27. Ito A., Nomura S., Hirota S., Suda J., Suda T., and Kitamura Y. Enhanced expression of CD34 messenger RNA by developing endothelial cells of mice. Lab Invest 5 (1995) 532-538
28. Shmelkov S.V., St Clair R., Lyden D., and Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 4 (2005) 715-719
29. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 3 (1992) 1579-1586
30. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 6535 (1995) 62-66
31. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 3 (2000) 952-958
32. Friedrich E.B., Walenta K., Scharlau J., Nickenig G., and Werner N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 3 (2006) e20-e25
33. Timmermans F., Van Hauwermeiren F., De Smedt M., Raedt R., Plasschaert F., De B.M.l., et al. Endothelial outgrowth cells are not derived from CD133 + cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol 7 (2007) 1572-1579
34. Case J., Mead L.E., Bessler W.K., Prater D., White H.A., Saadatzadeh M.R., et al. Human CD34+ AC133+ VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 7 (2007) 1109-1118
35. Schmidt-Lucke C., Rossig L., Fichtlscherer S., Vasa M., Britten M., Kamper U., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 22 (2005) 2981-2987
36. Timmermans F., Plum J., Yoder M.C., Ingram D.A., Vandekerckhove B., and Case J. Endothelial progenitor cells: identity defined. J Cell Mol Med (2008)
37. Holthofer H., Virtanen I., Kariniemi A., Hormia M., Linder E., and Miettinen A. Ulex Europaeus I Lectin as a marker for vascular endothelium in human tissues. Lab Invest 1 (1982) 60-66
38. Voyta J.C., Via D.P., Butterfield C.E., and Zetter B.R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 6 (1984) 2034-2040
39. Suzuki K., Sakata N., Kitani A., Hara M., Hirose T., Hirose W., et al. Characterization of human monocytic cell line, U937, in taking up acetylated low-density lipoprotein and cholesteryl ester accumulation: a flow cytometric and HPLC study. Biochim Biophys Acta 2 (1990) 210-216
40. Schwechheimer K., Weiss G., Schnabel P., and Moller P. Lectin target cells in human central nervous system and the pituitary gland. Histochemistry 2 (1984) 165-169
41. Liu S.M., and Li C.Y. Immunohistochemical study of ulex europaeus agglutinin 1 (UEA-1) binding of megakaryocytes in bone marrow biopsy specimens: demonstration of heterogeneity in staining pattern reflecting the stages of differentiation. Hematopathol Mol Hematol 1-2 (1996) 99-109
42. Graziano M., St-Pierre Y., and Potworowski E.F. UEA-I-binding to thymic medullary epithelial cells selectively reduces numbers of cortical TCRalphabeta+ thymocytes in FTOCs. Immunol Lett 3 (2001) 143-150
43. Delwel R., Touw I., Bot F., and Lowenberg B. Fucose Binding Lectin for Characterizing Acute Myeloid Leukemia Progenitor Cells. Blood 1 (1986) 41-45
44. Ingram D.A., Lien I.Z., Mead L.E., Estes M., Prater D.N., Derr-Yellin E., et al. In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function. Diabetes 3 (2008) 724-731
45. Ingram D.A., Mead L.E., Moore D.B., Woodard W., Fenoglio A., and Yoder M.C. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 7 (2005) 2783-2786
46. Wassmann S., Werner N., Czech T., and Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 8 (2006) e74-e83
47. Aicher A., Rentsch M., Sasaki K., Ellwart J.W., Fandrich F., Siebert R., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 4 (2007) 581-589
48. Sengenes C., Miranville A., Maumus M., De Barros S., Busse R., and Bouloumie A. Chemotaxis and differentiation of human adipose tissue CD34+/CD31- progenitor cells: role of stromal derived factor-1 released by adipose tissue capillary endothelial cells. Stem Cells 9 (2007) 2269-2276
49. Mikkola H.K., Gekas C., Orkin S.H., and Dieterlen-Lievre F. Placenta as a site for hematopoietic stem cell development. Exp Hematol 9 (2005) 1048-1054
50. Gekas C., Dieterlen-Lievre F., Orkin S.H., and Mikkola H.K. The Placenta Is a Niche for Hematopoietic Stem Cells. Dev Cell 3 (2005) 365-375
51. Challier J.C., Galtier M., Cortez A., Bintein T., Rabreau M., and Uzan S. Immunocytological evidence for hematopoiesis in the early human placenta. Placenta 4 (2005) 282-288
52. Yoon C.H., Hur J., Park K.W., Kim Jh., Lee C.s., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 11 (2005) 1618-1627
53. Smadja D.M., Bieche I., Susen S., Mauge L., Laurendeau I., D'audigier C., et al. Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. J Cell Mol Med (2008)
54. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 5 (2005) 733-742
55. Kocher A.A., Schuster M.D., Bonaros N., Lietz K., Xiang G., Martens T.P., et al. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 4 (2006) 455-464
56. He T., Peterson T.E., and Katusic Z.S. Paracrine mitogenic effect of human endothelial progenitor cells: role of interleukin-8. Am J Physiol Heart Circ Physiol 2 (2005) H968-H972
57. Smadja D.M., Bieche I., Uzan G., Bompais H., Muller L., Boisson-Vidal C., et al. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 11 (2005) 2321-2327
58. Smadja D.M., Laurendeau I., Avignon C., Vidaud M., Aiach M., and Gaussem P. The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost 9 (2006) 2051-2058
59. Fridman R., Toth M., Pena D., and Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 12 (1995) 2548-2555
60. Opitz C.A., Rimmerman N., Zhang Y., Mead L.E., Yoder M.C., Ingram D.A., et al. Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. FEBS Lett 25 (2007) 4927-4931
61. Heissig B., Hattori K., Dias S., Friedrich M., Ferris B., Hackett N.R., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 5 (2002) 625-637
62. Aicher A., Heeschen C., Mildner-Rihm C., Urbich C., Ihling C., Technau-Ihling K., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 11 (2003) 1370-1376
63. Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 25 (2003) 3115-3121
64. Iwakura A., Shastry S., Luedemann C., Hamada H., Kawamoto A., Kishore R., et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 12 (2006) 1605-1614
65. De Falco E., Porcelli D., Torella A., Straino S., Iachininoto Mg., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 12 (2004) 3472-3482
66. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 2 (2006) 226-235
67. Tojo T., Ushio-Fukai M., Yamaoka-Tojo M., Ikeda S., Patrushev N., and Alexander R.W. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 18 (2005) 2347-2355
68. Urao N., Inomata H., Razvi M., Kim H.W., Wary K., Mckinney R., et al. Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ Res 2 (2008) 212-220
69. Chavakis E., Aicher A., Heeschen C., Sasaki K., Kaiser R., El Makhfi N., et al. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 1 (2005) 63-72
70. Chavakis E., Hain A., Vinci M., Carmona G., Bianchi M.E., Vajkoczy P., et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2 (2007) 204-212
71. Jin H., Aiyer A., Su J., Borgstrom P., Stupack D., Friedlander M., et al. Homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 3 (2006) 652-662
72. Urbich C., Heeschen C., Aicher A., Sasaki K., Bruhl T., Farhadi M.R., et al. Cathepsin l is required for endothelial progenitor cell-induced neovascularization. Nat Med 2 (2005) 206-213
73. Zeng L., Xiao Q., Margariti A., Zhang Z., Zampetaki A., Patel S., et al. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol 7 (2006) 1059-1069
74. Rossig L., Urbich C., Bruhl T., Dernbach E., Heeschen C., Chavakis E., et al. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 11 (2005) 1825-1835
75. Piqueras L., Reynolds A.R., Hodivala-Dilke K.M., Alfranca A., Redondo J.M., Hatae T., et al. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 1 (2007) 63-69
76. Lancrin C., Sroczynska P., Stephenson C., Allen T., Kouskoff V., and Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 7231 (2009) 892-895
77. Drake C.J., and Fleming P.A. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 5 (2000) 1671-1679
78. Noden D.M. Embryonic origins and assembly of blood vessels. Am Rev Respir Dis 4 (1989) 1097-1103
79. Pardanaud L., and Dieterlen-Lievre F. Does the paraxial mesoderm of the avian embryo have hemangioblastic capacity?. Anat Embryol (Berl) 4 (1995) 301-308
80. Vokes S.A., and Krieg P.A. Endoderm is required for vascular endothelial tube formation, but not for angioblast specification. Development 3 (2002) 775-785
81. Flamme I., and Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 2 (1992) 435-439
82. Chang H., Huylebroeck D., Verschueren K., Guo Q., Matzuk M.M., and Zwijsen A. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 8 (1999) 1631-1642
83. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 6573 (1996) 435-439
84. Takashima S., Kitakaze M., Asakura M., Asanuma H., Sanada S., Tashiro F., et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl Acad Sci U S A 6 (2002) 3657-3662
85. Ryan H.E., Lo J., and Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 11 (1998) 3005-3015
86. Van Der Zwaag B., Hellemons A.J., Leenders W.P., Burbach J.P., Brunner H.G., Padberg G.W., et al. PLEXIN-D1, a novel plexin family member, is expressed in vascular endothelium and the central nervous system during mouse embryogenesis. Dev Dyn 3 (2002) 336-343
87. Wang H.U., Chen Z.F., and Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 5 (1998) 741-753
88. Peppel K., Zhang L., Orman E.S., Hagen P.O., Amalfitano A., Brian L., et al. Activation of vascular smooth muscle cells by TNF and PDGF overlapping and complementary signal transduction mechanisms. Cardiovasc Res 3 (2005) 674-682
89. Sugawara J., Mitsui-Saito M., Hoshiai T., Hayashi C., Kimura Y., and Okamura K. Circulating endothelial progenitor cells during human pregnancy. J Clin Endocrinol Metab 3 (2005) 1845-1848
90. Buemi M., Allegra A., D'anna R., Coppolino G., Crasci E., Giordano D., et al. Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol 1 68 (2007) e61-e66
91. Savvidou M.D., Xiao Q., Kaihura C., Anderson J.M., and Nicolaides K.H. Maternal circulating endothelial progenitor cells in normal singleton and twin pregnancy. Am J Obstet Gynecol 4 414 (2008) e411-e415
92. Sugawara J., Mitsui-Saito M., Hayashi C., Hoshiai T., Senoo M., Chisaka H., et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 9 (2005) 5329-5332
93. Matsubara K., Abe E., Matsubara Y., Kameda K., and Ito M. Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2 (2006) 79-85
94. Javed M.J., Mead L.E., Prater D., Bessler W.K., Foster D., Case J., et al. Endothelial colony forming cells and mesenchymal stem cells are enriched at different gestational ages in human umbilical cord blood. Pediatr Res 1 (2008) 68-73
95. Case J., Ingram D.A., and Haneline L.S. Oxidative stress impairs endothelial progenitor cell function. Antioxid Redox Signal 11 (2008) 1895-1907
96. Barker D.J. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2 (2006) 270-283
97. Han J.K., Lee H.S., Yang H.M., Hur J., Jun S.I., Kim J.Y., et al. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Circulation 10 (2008) 1021-1033
98. Sugiura T., Kondo T., Kureishi-Bando Y., Numaguchi Y., Yoshida O., Dohi Y., et al. Nifedipine improves endothelial function: role of endothelial progenitor cells. Hypertension 3 (2008) 491-498
99. Imanishi T., Kobayashi K., Kuroi A., Ikejima H., and Akasaka T. Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell. Hypertens Res 4 (2008) 757-765
100. Yao E.H., Fukuda N., Matsumoto T., Kobayashi N., Katakawa M., Yamamoto C., et al. Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect. Hypertens Res 11 (2007) 1119-1128
101. Yu Y., Fukuda N., EH Y., Matsumoto T., Kobayashi N., Suzuki R., et al. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Am J Hypertens 1 (2008) 72-77
102. Bahlmann F.H., De Groot K., Mueller O., Hertel B., Haller H., and Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 4 (2005) 526-529
103. D'uscio L.V., Smith L.A., Santhanam A.V., Richardson D., Nath K.A., and Katusic Z.S. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 5 (2007) 1142-1148
104. Urao N., Okigaki M., Yamada H., Aadachi Y., Matsuno K., Matsui A., et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 11 (2006) 1405-1413
105. Dimmeler S., Aicher A., Vasa M., Mildner-Rihm C., Adler K., Tiemann M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 3 (2001) 391-397
106. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 25 (2002) 3017-3024
107. Diller G.P., Van Eijl S., Okonko D.O., Howard L.S., Ali O., Thum T., et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation 23 (2008) 3020-3030
108. Laufs U., Urhausen A., Werner N., Scharhag J., Heitz A., Kissner G., et al. Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil 4 (2005) 407-414
109. Laufs U., Werner N., Link A., Endres M., Wassmann S., Jurgens K., et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2 (2004) 220-226
110. Herrler T., Leicht S.F., Huber S., Hermann P.C., Schwarz T.M., Kopp R., et al. Prostaglandin E positively modulates endothelial progenitor cell homeostasis: an advanced treatment modality for autologous cell therapy. J Vasc Res 4 (2009) 333-346
111. Duda D.G., Cohen K.S., Scadden D.T., and Jain R.K. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 4 (2007) 805-810